SuperworthBecton, Dickinson and EPS BDX
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- $3.31
- Latest quarter, Q3 FY26
- $1.37
- −32% on a year earlier
- Fiscal year 2025
- $5.82
- −1% on the year before
Becton, Dickinson and's earnings per share was $3.31 over the twelve months to Jun 30, 2026, down 40% on a year earlier.
In its latest quarter, Q3 FY26, it was $1.37, down 31% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 16% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $5.82 | −1% |
| FY2024 | $5.86 | +18% |
| FY2023 | $4.96 | −16% |
| FY2022 | $5.88 | −14% |
| FY2021 | $6.85 | +151% |
| FY2020 | $2.73 | −31% |
| FY2019 | $3.94 | +795% |
| FY2018 | $0.44 | −91% |
| FY2017 | $4.65 | +3% |
| FY2016 | $4.51 | +32% |
| FY2015 | $3.41 | −43% |
| FY2014 | $5.99 | −8% |
| FY2013 | $6.49 | +16% |
| FY2012 | $5.61 | −0% |
| FY2011 | $5.62 | +2% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $1.37 | −32% | $3.31 | |
| Q2 FY26 | −$1.11 | −204% | $3.94 | |
| Q1 FY26 | $1.34 | +29% | $6.12 | |
| Q4 FY25 | $1.71 | +25% | $5.82 | |
| Q3 FY25 | $2.00 | +19% | $5.48 | |
| Q2 FY25 | $1.07 | −42% | $5.16 | |
| Q1 FY25 | $1.04 | +8% | $5.94 | |
| Q4 FY24 | $1.37 | +270% | $5.86 | |
| Q3 FY24 | $1.68 | +24% | $4.86 | |
| Q2 FY24 | $1.85 | +21% | $4.54 | |
| Q1 FY24 | $0.96 | −44% | $4.22 | |
| Q4 FY23 | $0.37 | −60% | $4.96 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Becton, Dickinson and's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| BDXBecton, Dickinson and | $3.31 | −40% a year |
| MDLNMedline | n/m | |
| RMDResMed | $10.43 | +10% a year |
| WSTWest Pharmaceutical Services | $7.81 | +17% a year |
| ISRGIntuitive Surgical | $8.27 | +9% a year |
| SOLVSolventum | $8.18 | +277% a year |
| PENPenumbra | $4.07 | +8% a year |
| COOCooper Companies | $2.93 | +44% a year |
| ALGNAlign Technology | $5.75 | −3% a year |
| GMEDGlobus Medical | $3.91 | +50% a year |
| PODDInsulet | $5.35 | +64% a year |
| Peer median | $5.75 |
Where Becton, Dickinson and ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Becton, Dickinson and
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.